Please sign in to follow a disease.
Carbs under the microscope: new study tests how carb type and amount impact metabolism
NCT ID NCT07533513
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the amount and type of carbohydrates in your diet affect blood sugar, fats, and gut health. Twenty adults with or at risk for metabolic syndrome will eat four different carb diets in a random order. The goal is to understand which carb patterns are best for metabolism.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dietary carbohydrate (varying quantity and glycemic index)
- What this could lead to
- If successful, this could help design better dietary guidelines for managing or preventing metabolic syndrome.
- What could go wrong
- This is a small, early-stage study with only 20 participants, so results may not apply broadly. Dietary interventions are hard to control outside the lab.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male and female aged 18 - 65 years; * BMI 20 - 35 kg/m2; * Consent to be randomly assigned to an intervention or control group; * Willingness to eat the food and beverages provided in the study; * Patients with or at high risk of metabolic syndrome, and the diagnostic criteria of metabolic syndrome were based on the Chinese Guidelines for the Prevention and Treatment of diabetes (2024 edition). Exclusion Criteria: * Use of medications that affect blood glucose metabolism; * Familial hyperlipidemia, or use of drugs that affect lipid metabolism; * Long-term or current use of nonsteroidal anti-inflammatory drugs, antibiotics, antihistamines, or immunomodulatory drugs, and unable to stop taking these drugs within 72 h before the start of the study; * Use of hormonal medications such as anticoagulants, anabolic steroids, and hydrocortisone; * Have a history of serious illness, or are in the acute stage of cardiovascular, renal, thyroid, gastrointestinal, hepatobiliary, immunologic, respiratory, neurological, musculoskeletal, psychiatric, infectious, and malignant diseases, and are receiving treatment or use of related drugs; * Self-reported weight gain or loss of more than 7 kg in the 6 months before enrollment; * Vegetarian; * Have food allergies or other problems that may affect food intake; * Unable to consume only the food and beverages provided in the study; * Drink alcohol more than 2 times per day, more than 14 times per week, and unwillingness to stop drinking during the study; * Participate in a weight-loss program; * Unwillingness to maintain weight throughout the study; * Females who have given birth within the past year, are pregnant or plan to become pregnant within 6 months, are breastfeeding; * Intend to participate in other dietary intervention studies and drug use studies in the next 4 months; * Poor venous blood access; * Any other that the physician assessed as unsuitable for the trial conditions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome (METS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sun Yat-sen University
Shenzhen, Guangdong, 518107, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sugary drink before Weight-Loss surgery speed up gut recovery?
- A cheap blood test could flag hidden liver fat in metabolic syndrome
- Can Time-Restricted eating tame insulin resistance? a new study aims to find out
- A reversible gut sleeve could offer a new way to treat obesity
- Metformin pause: does a Two-Week break worsen blood sugar control?
- Fatty acid bars show promise for metabolic syndrome